Healthtell

The bioinformatics startup has also invested in six other companies, committing $400 million to its data-sharing collaboration.

The firm has not disclosed the specific disease the test will address but has determined this space represents the best opportunity for its array technology.

The company, which also raised $14 million in a Series A round, plans to use the proceeds to commercialize panels of tests for autoimmune diseases.

The work found that individuals have steady immunosignatures over time, suggesting longitudinal testing could prove effective for early disease detection.

The funds will support work to evaluate the effectiveness of the company's immunosignature technology in the diagnosis of brain cancer.

NEW YORK (GenomeWeb) – Having refined its platform and manufacturing process, diagnostics firm HealthTell has now moved into clinical feasibility studies with the aim of launching its first test by the end of next year, CEO Bill Colston told ProteoMonitor this week.

Vermillion has named David Jansen its VP of marketing, a new position at the firm. Jansen joins Vermillion from Myriad Genetics, where he held senior marketing roles for the past seven years.

NEW YORK (GenomeWeb) – In a study published this week in Proceedings of the National Academy of Sciences, researchers at Arizona State University's Biodesign Institute demonstrated the ability o

Biotech firm HealthTell said this week that it has raised $4 million to support development of its immunosignature diagnostic technology.

People In The News

NEW YORK (GenomeWeb News) – The National Institute of General Medical Sciences has appointed Susan Gregurick to direct its Division of Biomedical Technology, Bioinformatics, and Computational Biology.

Pages

Customers might want to consider what they might learn about their risk of diseases like Alzheimer's before snagging the genetic testing kits that are on many gift guides this year, NJ.com writes.

The Wall Street Journal reports there is uncertainty surrounding whether He Jiankui's embryo editing did what he said it did.

Stat News reports that the pause on procuring fetal tissue for intramural US National Institutes of Health research will soon affect additional labs there.

In Nature this week: genomic analysis of the invasive fall webworm, amp of constrained coding regions within the human genome, and more.